Table 3

Prevalence and associations of SIL with age, HPV, and HIV among 607 antenatal clinic attenders with cytology

SIL positive/ total (%)OR (95% CI)*
*Odds ratios for HPV and HIV are adjusted for age.
†Among the 607 women with cytology, HPV status was unknown for 46 women, and not typeable for 60 women.
‡HIV status was unknown for four women with cytology.
Total43/607 (7%)
Age group (years)
15–197/148 (5%)1.00
20–2928/381 (7%)1.59 (0.7–3.7)
30–448/78 (10%)2.30 (0.8–6.6)
Residence of current partner
Same household35/548 (6%)1.00
Elsewhere8/59 (14%)2.30 (1.0–5.2)
HPV negative†16/371 (4%)1.00
HPV positive26/190 (14%)3.66 (1.9–7.0)
High risk (HR) types18/107 (17%)4.75 (2.3–9.8)
Low risk (LR) types2/23 (9%)2.17 (0.5–10.1)
HIV negative‡33/513 (6%)1.00
HIV positive9/90 (10%)1.54 (0.7–3.4)
HPV− HIV−13/311 (4%)1.00
HPV− HIV+3/59 (5%)1.20 (0.3–4.4)
HPV+ HIV−19/159 (12%)3.24 (1.6–6.8)
HPV+ HIV+6/28 (21%)6.16 (2.1–17.9)